Personalized medicine in breast cancer: Tamoxifen, endoxifen, and CYP2D6 in clinical practice

Kathryn J. Ruddy, Stephen D. Desantis, Rebecca S. Gelman, Alan H.B. Wu, Rinaa S. Punglia, Erica L. Mayer, Sara M. Tolaney, Eric P. Winer, Ann H. Partridge, Harold J. Burstein

Research output: Contribution to journalArticle

18 Scopus citations

Fingerprint Dive into the research topics of 'Personalized medicine in breast cancer: Tamoxifen, endoxifen, and CYP2D6 in clinical practice'. Together they form a unique fingerprint.

Medicine & Life Sciences